• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年跨性别医学中的临床药理学

Clinical pharmacology in adolescent transgender medicine.

作者信息

Cirrincione Lauren R, Huang Kai J, Sequeira Gina M

机构信息

Department of Pharmacy, University of Washington, Seattle, WA, USA.

School of Medicine, University of California San Francisco, San Francisco, CA, USA.

出版信息

Br J Clin Pharmacol. 2024 Oct;90(10):2387-2397. doi: 10.1111/bcp.16213. Epub 2024 Aug 26.

DOI:10.1111/bcp.16213
PMID:39187392
Abstract

Adolescent transgender medicine is a growing clinical field. Gender-affirming medications for transgender youth may include gonadotropin-releasing hormone (GnRH) agonists, gender-affirming hormones or both. To evaluate the potential effects of GnRH agonists (puberty suppression) on pharmacokinetic processes for transgender youth, we searched PubMed from inception to May 2024 for publications on the effects of GnRH agonists on drug absorption, distribution, metabolism or excretion for transgender adolescents or effects on hormones (including gonadotropins, adrenal androgens, sex steroids) that are associated with changes in drug metabolism during puberty in the general adolescent population. No publications discussed the effects of GnRH agonist treatment on pharmacokinetic processes for adolescent transgender people. Sixteen publications observed marked decreases in gonadotropins and sex steroids for both adolescent transgender men and adolescent transgender women and slight effects on adrenal androgens. During GnRH agonist treatment, changes in body composition and body shape were greater for adolescent transgender people than for cisgender adolescent people. Further research is needed to better understand the effects of GnRH agonists on drug metabolism and other pharmacokinetic processes for transgender adolescents receiving GnRH agonists and other gender-affirming medications.

摘要

青少年跨性别医学是一个不断发展的临床领域。用于跨性别青少年的性别肯定药物可能包括促性腺激素释放激素(GnRH)激动剂、性别肯定激素或两者皆有。为了评估GnRH激动剂(青春期抑制)对跨性别青少年药代动力学过程的潜在影响,我们检索了从创刊到2024年5月的PubMed,以查找关于GnRH激动剂对跨性别青少年药物吸收、分布、代谢或排泄的影响的出版物,或对一般青少年人群青春期期间与药物代谢变化相关的激素(包括促性腺激素、肾上腺雄激素、性类固醇)的影响的出版物。没有出版物讨论GnRH激动剂治疗对青少年跨性别者药代动力学过程的影响。16篇出版物观察到,青少年跨性别男性和青少年跨性别女性的促性腺激素和性类固醇均显著下降,对肾上腺雄激素的影响较小。在GnRH激动剂治疗期间,青少年跨性别者的身体成分和体型变化比顺性别青少年更大。需要进一步研究,以更好地了解GnRH激动剂对接受GnRH激动剂和其他性别肯定药物的跨性别青少年的药物代谢和其他药代动力学过程的影响。

相似文献

1
Clinical pharmacology in adolescent transgender medicine.青少年跨性别医学中的临床药理学
Br J Clin Pharmacol. 2024 Oct;90(10):2387-2397. doi: 10.1111/bcp.16213. Epub 2024 Aug 26.
2
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
3
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.口服药物,包括枸橼酸氯米芬或芳香化酶抑制剂与促性腺激素联合用于接受体外受精的女性的控制性卵巢刺激。
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3.
4
Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility.用于排卵障碍性不孕患者宫腔内人工授精的促排卵药物。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD005356. doi: 10.1002/14651858.CD005356.pub3.
5
Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse.宫腔内人工授精或性交尝试妊娠妇女的黄体支持。
Cochrane Database Syst Rev. 2022 Aug 24;8(8):CD012396. doi: 10.1002/14651858.CD012396.pub2.
6
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.对于月经过多进行子宫内膜破坏术前的子宫内膜减薄剂。
Cochrane Database Syst Rev. 2002(3):CD001124. doi: 10.1002/14651858.CD001124.
7
Treatments for seizures in catamenial (menstrual-related) epilepsy.月经性(与月经相关)癫痫发作的治疗。
Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3.
8
Gonadotrophin-releasing hormone antagonists for assisted conception.用于辅助生殖的促性腺激素释放激素拮抗剂
Cochrane Database Syst Rev. 2001(4):CD001750. doi: 10.1002/14651858.CD001750.
9
Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.子宫肌瘤患者在子宫切除术或肌瘤切除术之前的术前促性腺激素释放激素类似物治疗。
Cochrane Database Syst Rev. 2001(2):CD000547. doi: 10.1002/14651858.CD000547.
10
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.促黄体生成素释放激素激动剂用于绝经前女性早期乳腺癌的辅助治疗。
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD004562. doi: 10.1002/14651858.CD004562.pub4.

本文引用的文献

1
Growth and Adult Height Attainment in Danish Transgender Adolescents Treated With GnRH Analog and Sex Hormones.丹麦跨性别青少年接受 GnRH 类似物和性激素治疗后的生长和成年身高获得。
J Clin Endocrinol Metab. 2024 Oct 15;109(11):2764-2773. doi: 10.1210/clinem/dgae263.
2
A Holistic Framework for the Evaluation of Kidney Function in a Gender-Diverse Landscape.用于评估性别多样化环境下肾功能的整体框架。
Am J Kidney Dis. 2024 Aug;84(2):232-240. doi: 10.1053/j.ajkd.2024.01.522. Epub 2024 Mar 6.
3
A European Network for the Investigation of Gender Incongruence in adolescents.
一个调查青少年性别不一致的欧洲网络。
J Sex Med. 2024 Mar 28;21(4):350-356. doi: 10.1093/jsxmed/qdae014.
4
Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?回到未来:促性腺激素释放激素类似物(GnRHa)治疗跨性别和性别多样化青少年只是一个延长的评估阶段吗?
J Clin Endocrinol Metab. 2024 May 17;109(6):1565-1579. doi: 10.1210/clinem/dgad729.
5
Sex non-specific growth charts and potential clinical implications in the care of transgender youth.性别非特异性生长图表及其在跨性别青年护理中的潜在临床意义。
Front Endocrinol (Lausanne). 2023 Aug 11;14:1227886. doi: 10.3389/fendo.2023.1227886. eCollection 2023.
6
A PRISMA systematic review of adolescent gender dysphoria literature: 3) treatment.一项关于青少年性别焦虑症文献的PRISMA系统评价:3)治疗。
PLOS Glob Public Health. 2023 Aug 8;3(8):e0001478. doi: 10.1371/journal.pgph.0001478. eCollection 2023.
7
Extended Use of Histrelin Implant in Pediatric Patients.促性腺激素释放激素类似物植入剂在儿科患者中的长期使用。
Transgend Health. 2023 Jun 1;8(3):264-272. doi: 10.1089/trgh.2021.0130. eCollection 2023 Jun.
8
A systematic review of hormone treatment for children with gender dysphoria and recommendations for research.对性别焦虑儿童进行激素治疗的系统评价及研究建议。
Acta Paediatr. 2023 Nov;112(11):2279-2292. doi: 10.1111/apa.16791. Epub 2023 May 1.
9
Endocrinological Approach to Adolescents with Gender Dysphoria: Experience of a Pediatric Endocrinology Department in a Tertiary Center in Turkey.青春期性别认同障碍的内分泌学处理方法:土耳其一家三级中心儿科内分泌科的经验。
J Clin Res Pediatr Endocrinol. 2023 Aug 23;15(3):276-284. doi: 10.4274/jcrpe.galenos.2023.2023-1-13. Epub 2023 Mar 29.
10
Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.《阿姆斯特丹性别焦虑症队列中的儿童和青少年:荷兰协议实施的头 20 年中诊断和治疗轨迹的趋势》。
J Sex Med. 2023 Feb 27;20(3):398-409. doi: 10.1093/jsxmed/qdac029.